Table of Content




1. Introduction
1.1. Definition of Nuclear Medicine
1.2. Scope of the Report
1.3. Research Methodology


2. Executive Summary
2.1. Key Findings
2.2. Market Snapshot
2.3. Key Trends


3. Market Dynamics
3.1. Market Drivers
3.1.1. Rising Demand for Early Disease Diagnosis
3.1.2. Advancements in Nuclear Medicine Imaging Technologies
3.1.3. Growing Prevalence of Cancer and Cardiovascular Diseases
3.1.4. Other Market Drivers
3.2. Market Restraints
3.2.1. High Cost of Nuclear Medicine Equipment
3.2.2. Regulatory and Safety Concerns
3.2.3. Limited Availability of Radioisotopes
3.2.4. Other Market Restraints
3.3. Market Opportunities
3.3.1. Growing Investment in Radiopharmaceuticals
3.3.2. Increasing Application of Theranostics
3.3.3. Expansion of Nuclear Medicine in Emerging Markets
3.3.4. Other Market Opportunities


4. Global Nuclear Medicine Market Analysis
4.1. Market Size and Forecast (2024-2034)
4.2. Market Share Analysis by:
4.2.1. Product
4.2.1.1. Diagnostics
4.2.1.1.1. SPECT
4.2.1.1.2. PET
4.2.1.2. Therapeutics
4.2.1.2.1. Alpha Emitters
4.2.1.2.2. Beta Emitters
4.2.2. Application
4.2.2.1. Neurology
4.2.2.2. Cardiology
4.2.2.3. Oncology
4.2.2.4. Others
4.2.3. End User
4.2.3.1. Hospitals & Clinics
4.2.3.2. Diagnostic Centers
4.2.3.3. Others
4.3. Value Chain Analysis
4.4. SWOT Analysis
4.5. Porter’s Five Forces Analysis


5. Regional Market Analysis
5.1. North America
5.1.1. Market Overview
5.1.2. Market Size and Forecast
5.1.3. Key Trends
5.1.4. Competitive Landscape
5.2. Europe
5.2.1. Market Overview
5.2.2. Market Size and Forecast
5.2.3. Key Trends
5.2.4. Competitive Landscape
5.3. Asia Pacific
5.3.1. Market Overview
5.3.2. Market Size and Forecast
5.3.3. Key Trends
5.3.4. Competitive Landscape
5.4. Latin America
5.4.1. Market Overview
5.4.2. Market Size and Forecast
5.4.3. Key Trends
5.4.4. Competitive Landscape
5.5. Middle East & Africa
5.5.1. Market Overview
5.5.2. Market Size and Forecast
5.5.3. Key Trends
5.5.4. Competitive Landscape


6. Competitive Landscape
6.1. Market Share Analysis of Key Players
6.2. Company Profiles of Key Players
6.2.1. GE Healthcare
6.2.2. Siemens Healthineers
6.2.3. Cardinal Health, Inc.
6.2.4. Bracco Imaging S.p.A.
6.2.5. Curium Pharma
6.2.6. Jubilant Radiopharma
6.2.7. Lantheus Holdings, Inc.
6.2.8. Bayer AG
6.2.9. Advanced Accelerator Applications (a Novartis company)
6.2.10. NorthStar Medical Radioisotopes, LLC
6.3. Recent Developments and Innovations
6.4. Strategic Initiatives


7. Future Outlook and Market Forecast
7.1. Market Growth Prospects
7.2. Technological Trends and Innovations
7.3. Investment Opportunities
7.4. Strategic Recommendations


8. Key Insights and Reiteration of Main Findings

9. Future Prospects for the Global Nuclear Medicine Market



List of Figures

List of Figures:

Figure 1: Global Nuclear Medicine Market: Market Segmentation
Figure 2: Global Nuclear Medicine Market: Research Methodology
Figure 3: Top-Down Approach
Figure 4: Bottom-Up Approach
Figure 5: Data Triangulation and Validation
Figure 6: Global Nuclear Medicine Market: Drivers, Restraints, Opportunities, and Challenges
Figure 7: Global Nuclear Medicine Market: Porter’s Five Forces Model Analysis
Figure 8: Global Nuclear Medicine Market: Value Chain Analysis
Figure 9: Global Nuclear Medicine Market Share Analysis, By Product, 2024-2034
Figure 10: Global Nuclear Medicine Market Share Analysis, By Application, 2024-2034
Figure 11: Global Nuclear Medicine Market Share Analysis, By End User, 2024-2034
Figure 12: Global Nuclear Medicine Market Share Analysis, By Region, 2024-2034
Figure 13: North America Nuclear Medicine Market Share Analysis, By Product, 2024-2034
Figure 14: North America Nuclear Medicine Market Share Analysis, By Application, 2024-2034
Figure 15: North America Nuclear Medicine Market Share Analysis, By End User, 2024-2034
Figure 16: North America Nuclear Medicine Market Share Analysis, By Country, 2024-2034
Figure 17: Europe Nuclear Medicine Market Share Analysis, By Product, 2024-2034
Figure 18: Europe Nuclear Medicine Market Share Analysis, By Application, 2024-2034
Figure 19: Europe Nuclear Medicine Market Share Analysis, By End User, 2024-2034
Figure 20: Europe Nuclear Medicine Market Share Analysis, By Country, 2024-2034
Figure 21: Asia-Pacific Nuclear Medicine Market Share Analysis, By Product, 2024-2034
Figure 22: Asia-Pacific Nuclear Medicine Market Share Analysis, By Application, 2024-2034
Figure 23: Asia-Pacific Nuclear Medicine Market Share Analysis, By End User, 2024-2034
Figure 24: Asia-Pacific Nuclear Medicine Market Share Analysis, By Country, 2024-2034
Figure 25: Middle East and Africa Nuclear Medicine Market Share Analysis, By Product, 2024-2034
Figure 26: Middle East and Africa Nuclear Medicine Market Share Analysis, By Application, 2024-2034
Figure 27: Middle East and Africa Nuclear Medicine Market Share Analysis, By End User, 2024-2034
Figure 28: Middle East and Africa Nuclear Medicine Market Share Analysis, By Country, 2024-2034
Figure 29: South America Nuclear Medicine Market Share Analysis, By Product, 2024-2034
Figure 30: South America Nuclear Medicine Market Share Analysis, By Application, 2024-2034
Figure 31: South America Nuclear Medicine Market Share Analysis, By End User, 2024-2034
Figure 32: South America Nuclear Medicine Market Share Analysis, By Country, 2024-2034
Figure 33: Global Nuclear Medicine Market: Competitive Benchmarking
Figure 34: Global Nuclear Medicine Market: Vendor Share Analysis, 2024-2034
Figure 35: Global Nuclear Medicine Market: Key Player Strategies
Figure 36: Global Nuclear Medicine Market: Recent Developments and Innovations
Figure 37: Global Nuclear Medicine Market: Mergers and Acquisitions
Figure 38: Global Nuclear Medicine Market: SWOT Analysis of Key Players

List of Tables

List of Tables:

Table 1: Global Nuclear Medicine Market, By Product, 2024-2034 (USD Billion)
Table 2: Global Nuclear Medicine Market, By Diagnostics Type (SPECT, PET), 2024-2034 (USD Billion)
Table 3: Global Nuclear Medicine Market, By Therapeutics Type (Alpha Emitters, Beta Emitters), 2024-2034 (USD Billion)
Table 4: Global Nuclear Medicine Market, By Application, 2024-2034 (USD Billion)
Table 5: Global Nuclear Medicine Market, By Neurology, 2024-2034 (USD Billion)
Table 6: Global Nuclear Medicine Market, By Cardiology, 2024-2034 (USD Billion)
Table 7: Global Nuclear Medicine Market, By Oncology, 2024-2034 (USD Billion)
Table 8: Global Nuclear Medicine Market, By Other Applications, 2024-2034 (USD Billion)
Table 9: Global Nuclear Medicine Market, By End User, 2024-2034 (USD Billion)
Table 10: Global Nuclear Medicine Market, By Hospitals & Clinics, 2024-2034 (USD Billion)
Table 11: Global Nuclear Medicine Market, By Diagnostic Centers, 2024-2034 (USD Billion)
Table 12: Global Nuclear Medicine Market, By Other End Users, 2024-2034 (USD Billion)
Table 13: Global Nuclear Medicine Market, By Region, 2024-2034 (USD Billion)
Table 14: North America Nuclear Medicine Market, By Country, 2024-2034 (USD Billion)
Table 15: North America Nuclear Medicine Market, By Product, 2024-2034 (USD Billion)
Table 16: North America Nuclear Medicine Market, By Application, 2024-2034 (USD Billion)
Table 17: United States Nuclear Medicine Market, By Product, 2024-2034 (USD Billion)
Table 18: United States Nuclear Medicine Market, By Application, 2024-2034 (USD Billion)
Table 19: Canada Nuclear Medicine Market, By Product, 2024-2034 (USD Billion)
Table 20: Canada Nuclear Medicine Market, By Application, 2024-2034 (USD Billion)
Table 21: Europe Nuclear Medicine Market, By Country, 2024-2034 (USD Billion)
Table 22: Europe Nuclear Medicine Market, By Product, 2024-2034 (USD Billion)
Table 23: Europe Nuclear Medicine Market, By Application, 2024-2034 (USD Billion)
Table 24: Germany Nuclear Medicine Market, By Product, 2024-2034 (USD Billion)
Table 25: Germany Nuclear Medicine Market, By Application, 2024-2034 (USD Billion)
Table 26: U.K. Nuclear Medicine Market, By Product, 2024-2034 (USD Billion)
Table 27: U.K. Nuclear Medicine Market, By Application, 2024-2034 (USD Billion)
Table 28: France Nuclear Medicine Market, By Product, 2024-2034 (USD Billion)
Table 29: France Nuclear Medicine Market, By Application, 2024-2034 (USD Billion)
Table 30: Italy Nuclear Medicine Market, By Product, 2024-2034 (USD Billion)
Table 31: Italy Nuclear Medicine Market, By Application, 2024-2034 (USD Billion)
Table 32: Spain Nuclear Medicine Market, By Product, 2024-2034 (USD Billion)
Table 33: Spain Nuclear Medicine Market, By Application, 2024-2034 (USD Billion)
Table 34: Rest of Europe Nuclear Medicine Market, By Product, 2024-2034 (USD Billion)
Table 35: Rest of Europe Nuclear Medicine Market, By Application, 2024-2034 (USD Billion)
Table 36: Asia-Pacific Nuclear Medicine Market, By Country, 2024-2034 (USD Billion)
Table 37: Asia-Pacific Nuclear Medicine Market, By Product, 2024-2034 (USD Billion)
Table 38: Asia-Pacific Nuclear Medicine Market, By Application, 2024-2034 (USD Billion)
Table 39: China Nuclear Medicine Market, By Product, 2024-2034 (USD Billion)
Table 40: China Nuclear Medicine Market, By Application, 2024-2034 (USD Billion)
Table 41: India Nuclear Medicine Market, By Product, 2024-2034 (USD Billion)
Table 42: India Nuclear Medicine Market, By Application, 2024-2034 (USD Billion)
Table 43: Japan Nuclear Medicine Market, By Product, 2024-2034 (USD Billion)
Table 44: Japan Nuclear Medicine Market, By Application, 2024-2034 (USD Billion)
Table 45: South Korea Nuclear Medicine Market, By Product, 2024-2034 (USD Billion)
Table 46: South Korea Nuclear Medicine Market, By Application, 2024-2034 (USD Billion)
Table 47: Australia Nuclear Medicine Market, By Product, 2024-2034 (USD Billion)
Table 48: Australia Nuclear Medicine Market, By Application, 2024-2034 (USD Billion)
Table 49: Rest of Asia-Pacific Nuclear Medicine Market, By Product, 2024-2034 (USD Billion)
Table 50: Rest of Asia-Pacific Nuclear Medicine Market, By Application, 2024-2034 (USD Billion)
Table 51: Middle East and Africa Nuclear Medicine Market, By Product, 2024-2034 (USD Billion)
Table 52: Middle East and Africa Nuclear Medicine Market, By Application, 2024-2034 (USD Billion)
Table 53: South America Nuclear Medicine Market, By Product, 2024-2034 (USD Billion)
Table 54: South America Nuclear Medicine Market, By Application, 2024-2034 (USD Billion)
Table 55: Global Nuclear Medicine Market, Strategic Developments, 2024-2034
Table 56: Global Nuclear Medicine Market, Mergers & Acquisitions, 2024-2034
Table 57: Global Nuclear Medicine Market, New Product Launches, 2024-2034
Table 58: Global Nuclear Medicine Market, Collaborations and Partnerships, 2024-2034
Table 59: Global Nuclear Medicine Market, Investment Analysis, 2024-2034
Table 60: Global Nuclear Medicine Market, Technological Innovations, 2024-2034
Table 61: Global Nuclear Medicine Market, Future Trends and Opportunities, 2024-2034
Table 62: Global Nuclear Medicine Market, Key Insights and Recommendations, 2024-2034
Table 63: Global Nuclear Medicine Market, Competitive Landscape, 2024-2034
Table 64: Global Nuclear Medicine Market, Regional Analysis Summary, 2024-2034